Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19
Authors:
Preprint
Abstract
Summary: Previously, we and others have shown that SARS-CoV-2 spike-specific IgG antibodies play a major role in disease severity in COVID-19 by triggering macrophage hyperactivation, disrupting endothelial barrier integrity, and inducing thrombus formation. This hyper-inflammation is dependent on high levels of anti-spike IgG with aberrant Fc tail glycosylation, leading to Fcγ receptor hyper-activation. For development of immune-regulatory therapeutics, drug specificity is crucial to counteract excessive inflammation while simultaneously minimizing inhibition of antiviral immunity. We here developed an in vitro activation assay to screen for small molecule drugs that specifically counteract antibody-induced pathology. We identified that anti-spike induced inflammation is specifically blocked by small molecule inhibitors against SYK and PI3K. We identified SYK inhibitor entospletinib as the most promising candidate drug, which also counteracted anti-spike-induced endothelial dysfunction and thrombus formation. Moreover, entospletinib blocked inflammation by different SARS-CoV-2 variants of concern. Combined, these data identify entospletinib as a promising treatment for severe COVID-19. GraphicalKeywords
All Related Versions
- Published version: Life Science Alliance, 6 (11), e202302106.
This publication has 104 references indexed in Scilit:
- Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine KinaseJournal of Medicinal Chemistry, 2014
- The contribution of VEGF signalling to fostamatinib‐induced blood pressure elevationBritish Journal of Pharmacology, 2014
- Functional Roles of Syk in Macrophage-Mediated Inflammatory ResponsesMediators of Inflammation, 2014
- Syk inhibition with fostamatinib leads to transitional B lymphocyte depletionClinical Immunology, 2012
- Syk Regulates Multiple Signaling Pathways Leading to CX3CL1 Chemotaxis in MacrophagesJournal of Biological Chemistry, 2011
- The SYK tyrosine kinase: a crucial player in diverse biological functionsNature Reviews Immunology, 2010
- Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemiaBlood, 2010
- Syk-Mediated Translocation of PI3Kδ to the Leading Edge Controls Lamellipodium Formation and Migration of LeukocytesPLOS ONE, 2007
- Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophagesInnate Immunity, 2007
- Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 ReceptorCirculation Research, 2004